Flavopiridol in Treating Children With Relapsed or Refractory Solid Tumors or Lymphomas
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop
growing or die. Phase I trial to study the effectiveness of flavopiridol in treating children
who have relapsed or refractory solid tumors or lymphoma.